ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0968

Granzyme K+ CD8 T Cells Form the Core Population of Inflamed Human Tissue-associated CD8 T Cells

Anna Helena Jonsson1, Fan Zhang2, Emma Gomez-Rivas1, Gerald Watts1, Garett Dunlap3, Heather Faust1, Karishma Rupani1, Joseph Mears1, Deepak Rao1, Runci Wang4, Gregory Keras1, Nida Meednu5, Jonathan Coblyn1, Elena Massarotti1, Derrick Todd1, Andrew McDavid6, Jennifer Anolik5, Accelerating Medicines Partnership AMP: RA/SLE Network7, Kevin Wei1, Soumya Raychaudhuri1 and Michael Brenner8, 1Brigham and Women's Hospital, Boston, MA, 2Harvard Medical School, Boston, MA, 3Harvard University, Somerville, MA, 4Brigham and Women’s Hospital, Boston, MA, 5University of Rochester Medical center, Rochester, NY, 6University of Rochester, Rochester, NY, 7NIH/FNIH, Bethesda, MD, 8Brigham and Women's Hospital, Harvard Medical School, Newton, MA

Meeting: ACR Convergence 2021

Keywords: autoimmune diseases, immunology, rheumatoid arthritis, Synovitis, T Cell

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 7, 2021

Title: Abstracts: T Cell Biology & Targets in Autoimmune & Inflammatory Disease (0966–0969)

Session Type: Abstract Session

Session Time: 11:00AM-11:15AM

Background/Purpose: T cell-derived pro-inflammatory cytokines are a major driver of rheumatoid arthritis (RA) pathogenesis. While CD4 T cells have traditionally been assumed to be the main cytokine-producing T cells, CD8 T cells rival CD4 T cells in terms of both cell numbers and production of IFNγ and TNF. We found that the majority of CD8 T cells in synovial tissue and fluid are defined by high granzyme K (GzmK) expression and intermediate granzyme B (GzmB) expression, a pattern rare in blood. Here, we characterize the functions and differentiation of these tissue CD8 T cell subsets and describe the effects of GzmK on synovial fibroblasts.

Methods: Blood, synovial fluid, and synovial tissue were obtained from patients meeting the 2010 ACR criteria for RA. Single-cell RNA-seq data sets were generated by integrating new and publicly available data from synovial tissue and fluid from patients with RA and from blood from healthy controls. Synovial fibroblasts were stimulated with recombinant GzmK and/or cytokines for 24 hours prior to harvest of supernatants and RNA. Cytokine production was assessed by intracellular cytokine staining and flow cytometry or by enzyme-linked immunosorbent assay (ELISA). Gene expression changes were analyzed by RT-PCR or bulk RNA-sequencing (RNA-seq). In cross-disease analysis, GzmK and GzmB gene signatures were derived from RA synovial tissue data and applied to other tissue CD8 T cell profiles from publicly available scRNA-seq data.

Results: The vast majority of synovial CD8 T cells have a phenotype that is distinct from classic cytotoxic T lymphocytes, which express high levels of cytotoxic proteins such as granzyme B (GzmB), perforin, and granulysin (Fig. 1A). Instead, synovial CD8 T cell populations are dominated by GzmK+ GzmB+ CD8 T cells with low expression of perforin. Unlike GzmB, which activated caspases to induce target cell death, we find that GzmK does not induce cell death of synovial fibroblasts. Instead, we find that GzmK induces synovial fibroblasts to produce inflammatory factors such as IL-6 and CCL2. Moreover, GzmK can potentiate the effects of IFNg and TNF on synovial fibroblasts, thereby amplifying the effects of these T cell-derived cytokines in RA synovium (Fig. 1B). Using single-cell TCR repertoire studies to track sister clones among­ matched blood and synovial CD8 T cells, we have identified migration and differentiation pathways that lead to the accumulation of GzmK+ GzmB+ CD8 T cells in inflamed joints. Further, we found transcriptomically similar CD8 T cells in both healthy and diseased tissues, including bowel from patients with inflammatory bowel disease and bronchoalveolar lavage fluid from patients with severe COVID-19 (Fig. 1C).

Conclusion: These findings suggest that GzmK+ GzmB+ CD8 T cells form a core population of tissue-associated T cells in humans that has the potential to drive inflammation both by production of inflammatory cytokines and by direct effects of granzyme K on other cells.

Figure. 1. (A) UMAP plot of Louvain clustering of 4,111 single-cell RNA-seq profiles from synovial tissue T cells. (B) IL-6 production by synovial fibroblasts after stimulation with recombinant GzmK and/or IFNg for 24 hours. (C) GzmK and GzmB scores were derived from scRNA-seq data from CD8 T cells from RA synovial tissue and applied to publicly available scRNA-seq profiles of CD8 T cells from other healthy and diseased tissues.


Disclosures: A. Jonsson, Amgen, 5; F. Zhang, None; E. Gomez-Rivas, None; G. Watts, None; G. Dunlap, None; H. Faust, None; K. Rupani, None; J. Mears, None; D. Rao, Janssen, 5, 6, Bristol-Myers Squibb, 1, 5, Scipher Medicine, 2, Pfizer, 6, Merck, 6; R. Wang, None; G. Keras, Takeda, 3; N. Meednu, None; J. Coblyn, CVS, 1; E. Massarotti, None; D. Todd, Up to Date, 9; A. McDavid, None; J. Anolik, None; A. AMP: RA/SLE Network, Several (FNIH-sponsored consortium), 5; K. Wei, Mestag, 2; S. Raychaudhuri, Mestag Therapeutics, 2, 12, Founder, Johnson & Johnson, 1, 2, Pfizer, 1, 2, Biogen, 5, Gilead Sciences, 2; M. Brenner, GSK, 2, 4FO Ventures, 2, Mestag Therapeutics, 2, 11.

To cite this abstract in AMA style:

Jonsson A, Zhang F, Gomez-Rivas E, Watts G, Dunlap G, Faust H, Rupani K, Mears J, Rao D, Wang R, Keras G, Meednu N, Coblyn J, Massarotti E, Todd D, McDavid A, Anolik J, AMP: RA/SLE Network A, Wei K, Raychaudhuri S, Brenner M. Granzyme K+ CD8 T Cells Form the Core Population of Inflamed Human Tissue-associated CD8 T Cells [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/granzyme-k-cd8-t-cells-form-the-core-population-of-inflamed-human-tissue-associated-cd8-t-cells/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/granzyme-k-cd8-t-cells-form-the-core-population-of-inflamed-human-tissue-associated-cd8-t-cells/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology